Monday, August 03, 2026 | 02:10 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Biocon Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹4,516.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.23 per cent from ₹4,173.00 crore. This corresponds to a year-on-year *(YoY) growth of 2.25 per cent.

Operating Profit

Operating Profit stands at ₹939.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 74.02 per cent from ₹540.10 crore. This corresponds to a year-on-year *(YoY) decline of 12.83 per cent.

PBDT

PBDT stands at ₹760.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.03 per cent from ₹447.50 crore. This corresponds to a year-on-year *(YoY) decline of 17.57 per cent.

Profit Before Tax

Profit Before Tax stands at ₹247.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 465.04 per cent from ₹-67.80 crore. This corresponds to a year-on-year *(YoY) decline of 49.16 per cent.

Net Profit

Net Profit stands at ₹198.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 483.40 per cent from ₹-51.80 crore. This represents a 56.77 per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Biocon Ltd Earnings

Data not available

Biocon Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Biocon Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 480Edelweiss Securities09-Dec-2025
Buy 476JM Financial08-Dec-2025
Buy 424JM Financial11-Aug-2025
Buy 430Motilal Oswal13-Jan-2025

Biocon Ltd Financial Reports

Filter By:
Loading...

Biocon Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Biocon-0.06%-1.54%0.24%18.10%15.46%11.30%
Laurus Labs1.76%3.30%18.76%55.69%85.19%110.78%
Dr Reddy's Labs0.28%1.05%-16.16%-10.90%-7.46%-6.35%
Aurobindo Pharma0.47%1.86%-0.91%14.80%30.34%44.77%
Alkem Lab-1.07%1.81%2.78%7.43%1.90%17.27%
Glenmark Pharma.1.28%2.22%-1.64%-6.66%14.06%7.68%
Abbott India0.72%-0.44%3.47%9.27%2.46%-18.38%

Company Info

Company Information

Chairperson : Kiran Mazumdar Shaw

Non-Exec & Non-Independent Dir : Ravi Mazumdar

Non-Exec & Non-Independent Dir : Eric Vivek Mazumdar

Lead Independent Director : Naina Lal Kidwai

Independent Non Exe. Director : Rekha Mehrotra Menon

Independent Non Exe. Director : NICHOLAS ROBERT HAGGAR

Independent Non Exe. Director : Atul Dhawan

Managing Director & CEO : Shreehas Pradeep Tambe

Company Sec. & Compli. Officer : RAJESH UMAKANT SHANOY

Biocon Ltd News

Data Not Available